Financial Performance Deteriorates Sharply in Q3 FY25-26
The primary catalyst for the downgrade is the significant decline in Narayana Hrudayalaya’s financial health during the quarter ended December 2025. The company’s financial trend score plummeted from a positive 7 to a negative -7 over the last three months, signalling a marked reversal in performance.
While net sales reached a record high of ₹2,151.17 crores, several profitability metrics have weakened. Operating profit to interest coverage ratio dropped to a low of 5.65 times, indicating reduced cushion to service debt costs. Profit after tax (PAT) fell by 19.5% to ₹171.20 crores compared to the average of the previous four quarters, signalling margin pressures. Concurrently, interest expenses surged to ₹65.03 crores, the highest recorded in recent quarters, further squeezing profitability.
Profit before tax excluding other income (PBT less OI) also declined to ₹179.39 crores, the lowest in recent periods, while earnings per share (EPS) dropped to ₹6.20, reflecting the earnings contraction. These financial setbacks have raised concerns about the company’s near-term earnings momentum and operational efficiency.
Valuation Reassessment: From Expensive to Fair
In tandem with the financial deterioration, the valuation grade for Narayana Hrudayalaya has shifted from expensive to fair. The company currently trades at a price-to-earnings (PE) ratio of 45.3, which, while high, is more reasonable relative to its hospital sector peers such as Fortis Healthcare and Global Health, which command PE ratios of 67.9 and 53.9 respectively.
Other valuation multiples include an enterprise value to EBITDA (EV/EBITDA) of 25.98 and a price-to-book value of 9.24. The PEG ratio stands elevated at 7.56, reflecting the disparity between price and earnings growth, as profits have only risen by 6% over the past year despite a 33.62% stock return. Return on capital employed (ROCE) remains robust at 23.62%, supporting the fair valuation stance.
Enterprise value to capital employed is at 8.31, indicating the stock is trading at a discount compared to historical averages of its peers. Dividend yield remains modest at 0.25%, consistent with the company’s reinvestment focus.
Our latest weekly pick is out! This Large Cap from Steel/Sponge Iron/Pig Iron delivered with target price and complete analysis. See what makes this week's selection special!
- - Latest weekly selection
- - Target price delivered
- - Large Cap special pick
Technical Indicators Turn Bearish
The technical outlook for Narayana Hrudayalaya has also weakened, shifting from mildly bullish to mildly bearish. Key momentum indicators such as the Moving Average Convergence Divergence (MACD) are mildly bearish on both weekly and monthly charts. The Relative Strength Index (RSI) remains neutral with no clear signal, while Bollinger Bands suggest sideways movement weekly but bullish trends monthly.
Daily moving averages have turned bearish, signalling short-term selling pressure. The Know Sure Thing (KST) indicator is mildly bearish weekly but bullish monthly, reflecting mixed momentum. Dow Theory analysis shows no clear trend weekly and mildly bearish monthly, while On-Balance Volume (OBV) is mildly bullish weekly but mildly bearish monthly, indicating volume trends are inconclusive.
These mixed technical signals suggest caution for traders, with the prevailing sentiment leaning towards a mild bearish bias in the near term.
Long-Term Quality and Market Performance Remain Strong
Despite recent setbacks, Narayana Hrudayalaya’s long-term quality metrics remain impressive. The company boasts an average ROCE of 25.88% and a return on equity (ROE) of 20.95%, underscoring efficient capital utilisation and shareholder returns. Net sales have grown at an annualised rate of 22.20%, while operating profit has surged by 83.59% over the long term.
Debt servicing capability is strong, with a low debt to EBITDA ratio of 0.46 times, indicating manageable leverage. The company’s market capitalisation grade remains low at 2, reflecting its mid-cap status within the hospital sector.
Market returns have been robust, with the stock delivering a 33.62% return over the past year, significantly outperforming the Sensex’s 8.64% and the broader BSE500’s 12.01% returns. Over longer horizons, the stock has generated extraordinary gains of 152.13% over three years, 300.34% over five years, and an exceptional 532.94% over ten years, far exceeding market benchmarks.
Holding Narayana Hrudayalaya Ltd from Hospital? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Promoter Confidence Dips Amidst Challenges
Adding to the concerns, promoter shareholding has declined by 0.58% in the previous quarter, now standing at 63.27%. This reduction may indicate diminished confidence from the company’s controlling stakeholders, which could weigh on investor sentiment.
While the company’s fundamentals remain strong, the combination of recent financial underperformance, technical weakness, and reduced promoter conviction has led to a cautious stance by analysts, reflected in the downgrade to a Sell rating with a Mojo Score of 45.0.
Summary and Outlook
Narayana Hrudayalaya Ltd’s recent downgrade from Hold to Sell is driven by a confluence of factors. The sharp deterioration in quarterly financial metrics, including a 19.5% fall in PAT and rising interest costs, has overshadowed record net sales. Technical indicators have turned mildly bearish, signalling potential near-term price pressure. Although valuation has become more reasonable relative to peers, the elevated PEG ratio and subdued profit growth temper enthusiasm.
Nevertheless, the company’s long-term growth trajectory, strong capital returns, and market-beating performance over multiple years remain compelling. Investors should weigh these strengths against the current headwinds and monitor upcoming quarterly results closely for signs of recovery or further weakness.
At the current price of ₹1,836.15, near its 52-week low of ₹1,325.00 but well below the 52-week high of ₹2,371.60, the stock presents a mixed picture. Caution is advised until financial trends stabilise and technical signals improve.
Key Financial and Market Data
Current Price: ₹1,836.15 | Previous Close: ₹1,844.50
52-Week High: ₹2,371.60 | 52-Week Low: ₹1,325.00
Market Cap Grade: 2 | Mojo Score: 45.0 (Sell)
One-Year Stock Return: 33.62% vs Sensex 8.64%
PEG Ratio: 7.56 | ROCE: 23.62% | ROE: 20.95%
Investment Implication
Given the downgrade, investors currently holding Narayana Hrudayalaya shares should reassess their positions in light of the recent financial and technical developments. While the company’s long-term fundamentals remain intact, the near-term outlook is clouded by earnings pressure and weakening market signals. Prospective investors may prefer to await clearer signs of recovery or consider alternative opportunities within the hospital sector.
About the Rating Change
The downgrade was effected on 19 Feb 2026 by MarketsMOJO, reflecting a comprehensive review of four key parameters: Quality, Valuation, Financial Trend, and Technicals. The company’s Mojo Grade shifted from Hold to Sell, signalling a more cautious stance based on the latest data.
Conclusion
Narayana Hrudayalaya Ltd’s recent rating downgrade underscores the importance of continuous monitoring of financial health and market dynamics. While the company’s long-term prospects remain promising, the current challenges warrant prudence. Investors should stay informed of quarterly results and sector developments to make well-informed decisions.
Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →
